JANUS HENDERSON GROUP PLC - BRIDGEBIO PHARMA INC ownership

BRIDGEBIO PHARMA INC's ticker is BBIO and the CUSIP is 10806X102. A total of 210 filers reported holding BRIDGEBIO PHARMA INC in Q4 2021. The put-call ratio across all filers is 0.63 and the average weighting 0.3%.

Quarter-by-quarter ownership
JANUS HENDERSON GROUP PLC ownership history of BRIDGEBIO PHARMA INC
ValueSharesWeighting
Q3 2023$30,156,005
+3930.0%
1,143,613
+2529.4%
0.02%
Q2 2023$748,294
-56.8%
43,493
-58.4%
0.00%
-100.0%
Q1 2023$1,731,561
+1544.4%
104,468
+655.5%
0.00%
Q4 2022$105,303
-23.2%
13,828
-50.0%
0.00%
Q3 2022$137,137
+7.1%
27,658
+96.6%
0.00%
Q2 2022$128,000
-9.2%
14,066
+1.6%
0.00%
Q1 2022$141,000
-39.0%
13,848
-0.1%
0.00%
Q4 2021$231,000
-99.8%
13,862
-99.5%
0.00%
-100.0%
Q3 2021$123,992,000
-27.6%
2,645,441
-5.9%
0.05%
-26.0%
Q2 2021$171,337,000
-3.2%
2,810,652
-2.2%
0.07%
-9.9%
Q1 2021$176,988,000
+39.6%
2,873,183
+61.1%
0.08%
+37.3%
Q4 2020$126,827,000
+99.8%
1,783,535
+5.4%
0.06%
+78.8%
Q3 2020$63,464,000
+10.2%
1,691,461
-4.2%
0.03%
+3.1%
Q2 2020$57,585,000
+11.2%
1,765,864
-1.1%
0.03%
-11.1%
Q1 2020$51,795,000
-53.0%
1,786,039
-43.1%
0.04%
-35.7%
Q4 2019$110,095,000
+1034.1%
3,141,081
+594.7%
0.06%
+1020.0%
Q3 2019$9,708,000
+4.0%
452,171
+30.7%
0.01%0.0%
Q2 2019$9,331,000345,9890.01%
Other shareholders
BRIDGEBIO PHARMA INC shareholders Q4 2021
NameSharesValueWeighting ↓
Aisling Capital Management LP 6,068,125$160,016,45665.94%
Kohlberg Kravis Roberts & Co. L.P. 31,060,971$819,077,80528.79%
Cormorant Asset Management, LP 4,662,530$122,950,9167.17%
Frazier Life Sciences Management, L.P. 2,725,949$71,883,2754.77%
Octagon Capital Advisors LP 971,639$25,622,1203.94%
M28 Capital Management LP 121,200$3,196,0443.66%
VIKING GLOBAL INVESTORS LP 25,120,991$662,440,5332.69%
BOONE CAPITAL MANAGEMENT LLC 313,381$8,263,8572.61%
Fernwood Investment Management, LLC 235,620$6,213,2992.23%
SOUTHPORT MANAGEMENT, L.L.C. 15,000$395,5502.15%
View complete list of BRIDGEBIO PHARMA INC shareholders